Champions Oncology (CSBR) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.98 +0.20%
Financial Fact:
Research and development: 1.21M
Today's EPS Names:
SQZB, ARDS, MDRX, More
Financial Fact:
Research and development: 1.21M
Today's EPS Names:
SQZB, ARDS, MDRX, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $16.6 million versus the consensus estimate of $16.43 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Momentus terminates $50M equity purchase agreement with Yield Point NY
- Zoom (ZM) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
